Search
for

    Sort by

    Research 121–150 of 1000+

    1. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    2. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    3. New drugs: Agalsidase beta Australian Prescriber · 2004
    4. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    5. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004
    6. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    7. Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome Frontiers in Endocrinology · 2025
    8. Obesity and the skin British Journal of Dermatology · 2011 · 128 citations
    9. Induction of versican by ascorbic acid 2-phosphate in dermal papilla cells Journal of Dermatological Science · 2006 · 22 citations
    10. Polycystic ovary syndrome Nature Reviews Disease Primers · 2016 · 883 citations
    11. Nonalcoholic fatty liver disease and polycystic ovary syndrome World Journal of Gastroenterology · 2014 · 114 citations
    12. MENSTRUAL DISORDERS IN ADOLESCENTS Pediatric Clinics of North America · 1999 · 75 citations
    13. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men The Journal of Steroid Biochemistry and Molecular Biology · 2012 · 8 citations
    14. Low Starch/Low Dairy Diet Results in Successful Treatment of Obesity and Co- Morbidities Linked to Polycystic Ovary Syndrome (PCOS) Journal of obesity and weight loss therapy · 2015 · 18 citations
    15. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2 Gynecological Endocrinology · 2007 · 9 citations
    16. Evaluation Asprosin Level in Polycystic Ovary Syndrome and Its Association with Fetuin a and Some Biochemical Parameter South Asian Research Journal of Pharmaceutical Sciences · 2023 · 1 citations
    17. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 131 citations
    18. POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE Anti-Aging Eastern Europe · 2024 · 2 citations
    19. Obesity and the skin: Skin physiology and skin manifestations of obesity Journal of The American Academy of Dermatology · 2007 · 405 citations
    20. Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones The American Journal of Medicine · 2006 · 155 citations
    21. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies Clinical medicine insights · 2019 · 129 citations
    22. Nutritional management in women with polycystic ovary syndrome: A review study Diabetes & Metabolic Syndrome: Clinical Research and Reviews · 2017 · 91 citations
    23. Polycystic Ovarian Syndrome Medical Clinics of North America · 2014 · 89 citations
    24. Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis Dermatology and Therapy · 2021 · 78 citations
    25. Pathways to inflammation: acne pathophysiology European Journal of Dermatology · 2011 · 68 citations
    26. Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies Materials Science and Engineering: C · 2019 · 64 citations
    27. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome International Journal of Molecular Sciences · 2020 · 58 citations
    28. Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review Nutrients · 2021 · 49 citations
    29. Endocrine-skin interactions Journal of The American Academy of Dermatology · 1988 · 46 citations
    30. Hirsutism: Diagnosis and management Gender Medicine · 2010 · 41 citations